Aktis Oncology, Inc.
Aktis Oncology, Inc. scores highest on Torque (68) and lowest on Earnings (26). Its PosiPenta is 43.03 out of 100, around the middle of similar companies.
On the Penta Grid this week, Aktis Oncology, Inc. is Grid #437 of 837 in the Healthcare sector in United States, and Grid #2,590 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Aktis Oncology, Inc. | 43.03 | 31 | 26 | 30 | 68 | 60 |
| Savara Inc. | 43.90 | 11 | 54 | 60 | 35 | 60 |
| MeiraGTx Holdings plc | 55.72 | 57 | 43 | 60 | 64 | 56 |
| QuidelOrtho Corporation | 40.97 | 46 | 44 | 35 | 31 | 49 |
| SpyGlass Pharma, Inc. | 48.43 | 19 | 23 | 72 | 77 | 51 |
| ArriVent BioPharma, Inc. | 39.97 | 26 | 20 | 46 | 65 | 43 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -8.86 |
| P/B ratio | 1.73 |
EEarnings
| Trailing EPS | ₹-161.02 |
| Forward EPS | ₹-202.23 |
NNitro
| Price | 1426.41 |
| 52-week high | 3238.30 |
| 52-week low | 1394.20 |
| Fall from 52-week high | 56.0% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | 0.02 |
AAnchor
| Beta (price swings) | — |
| Market cap | ₹7,933 Cr |
| Insider holding | 14.05% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Aktis Oncology, Inc.'s PosiPenta score?
Aktis Oncology, Inc.'s PosiPenta is 43.03 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Aktis Oncology, Inc. stand on the Penta Grid?
On the Penta Grid this week, Aktis Oncology, Inc. is Grid #437 of 837 in the Healthcare sector in United States, and Grid #2,590 of 4,000 in United States.
Which PosiPenta pillar is strongest for Aktis Oncology, Inc.?
Torque (durability), with a score of 68 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Aktis Oncology, Inc.?
Earnings (growth), with a score of 26 out of 100: weaker than most similar companies.
Has Aktis Oncology, Inc.'s PosiPenta changed since last week?
Yes, it rose 0.29 points, from 42.74 to 43.03.
PositoAI is for research and education only and is not investment advice.